BMS-986012

Generic Name
BMS-986012
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1894272-37-7
Unique Ingredient Identifier
Q8PK97HY9B
Background

BMS-986012 is a human antifucosyl-GM1 antibody. It is under investigation in clinical trial NCT02815592 (Trial of BMS-986012 in Combination With Platinum and Etoposide).

Associated Conditions
-
Associated Therapies
-

Study of BMS-986012 in Subjects With Small Cell Lung Caner

First Posted Date
2016-10-31
Last Posted Date
2019-08-12
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
7
Registration Number
NCT02949895
Locations
🇯🇵

Local Institution, Chuo-ku, Tokyo, Japan

Trial of BMS-986012 in Combination With Platinum and Etoposide

First Posted Date
2016-06-28
Last Posted Date
2024-05-23
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
12
Registration Number
NCT02815592
Locations
🇪🇸

Local Institution - 0002, Barcelona, Spain

🇪🇸

Local Institution - 0004, Madrid, Spain

🇪🇸

Local Institution - 0010, Malaga, Spain

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath